Numedico, the South Australian based manufacturer of safety medical devices and the manufacturer/distributor of ClickZip™ Needle Retractable Safety Syringe technology, has appointed Mana Medical Services to lead the Sales in Australia and New Zealand. Amelia Dickison, the Director and Founder of Mana Medical Services, will take on the position as Head of Sales.
Amelia has 20 years of experience in the pharmaceutical and medical device industry, working within sales, marketing, business development and training. Her experience and knowledge includes, but is not limited to, General Surgery, Hepatitis C, Gastroenterology, Mental Health, Cardiology, Erectile Dysfunction, Pain Management, Allergies, ENT, Obstetrics, Gynaecology, Oncology, Radiology, Women’s Imaging, Assisted Reproduction Technology, and IVF Labs. Her dedication towards helping healthcare professionals and their patients led her to create Mana Medical Services www.manamedicalservices.com.
Amelia says her decision to partner with Numedico was due to their purpose and mission being similar to hers. Amelia believes that the safety and wellbeing of health-care workers and patients should be a top priority and like Numedico wants to provide access to truly functional, practical and safe medical devices.
What are ClickZip™ Needle Retractable Safety Syringes?
ClickZip™ has been specifically designed to be used exactly like a traditional syringe but with the added benefit of a locking mechanism that ‘clicks’ into place when the needle is fully depressed. When the needle is retracted it is drawn back into the barrel. Once fully retracted the needle tilts to the side. The barrel plunger is then snapped off encapsulating the needle safely in the barrel thereby preventing reuse or needlestick injury.
With no leakage and minimal dead space, ClickZip™ meets international standards for medical devices and OSHA recommendations for needlestick safety devices. Latex free, the ClickZip™ Needle Retractable Safety Syringe been listed by the World Health Organisation (WHO) and has current US FDA 510K and ARTG approval, CE marked and ISO certification.
ClickZip™ is made from high quality materials; it is simple to use, safe, and reliable with an exchangeable and fully retractable needle. ClickZip™ is ideal and safe for many applications including: large-scale immunisation programmes; hospitals; veterinary and medical clinic applications.
See how it works
Go to www.numedico.com.au/technology to see how the ClickZip™ works.
Why the need for safety retractable syringes?
Every 60 minutes, of every day, six people suffer a needle stick injury somewhere in the world. Every day three people die as a result of those injuries. This simply does not need to happen.
It is estimated by the World Health Organisation (WHO) that 30 – 50% of some 12 billion injections given per year are administered unsafely. WHO reports in the World Health Report 2002, that of the 35- million health-care workers, 2 million experience percutaneous exposure to infectious diseases each year. It further notes that 37.6% of Hepatitis B, 39% of Hepatitis C and 4.4% of HIV/AIDS in health-care workers around the world are due to needlestick injuries. It is estimated that in the United States of America alone, over 320,000 needlestick injuries occur each year.
Syringe reuse is a worldwide problem and can result in the spread of blood borne pathogens. WHO estimates that 40% of the 16 billion injections annually administered worldwide involve reused, unsterilised syringes and needles, with rates of unsafe injections climbing to 70% in some countries.
The reuse of injection equipment is responsible worldwide for 32% of new HBV infections, 40% of new HCV infections, and 5% of all new HIV infections.
WHO defines a safe injection as one that:
- Does not expose the health-care worker to avoidable risk
- Does not result in waste that puts other people at risk
What are the risks?
There are more than 20 blood borne pathogens that can be transmitted by needlestick injuries. These include:
- Hepatitis B
- Hepatitis C
- Human immunodeficiency virus (HIV)
- Others including Syphilis, Herpes, Brucellosis…
For more information please contact: Neville Calvert | CEO | Numedico Technologies | +61 419 881 609 | firstname.lastname@example.org or Amelia Dickison | Director | Mana Medical Services | +61 488 700 288 | email@example.com
 WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings. WHO 2015.
 Terry Grimmond, FASM, BAgrSc, GrDpAdEd and Linda Good, PhD, RN, COHN-S, “EXPO-S.T.O.P.: A National Survey and Estimate of Sharps Injuries and Mucocutaneous Blood Exposures among Healthcare Workers in USA,” AOHP Journal, vol. 33, no. 4 (Fall 2013), pp. 31-36.
 Benedetta Allegranzi, The Burden of Unsafe Injections Worldwide: Highlights on Recent Improvements and Areas Requiring Urgent Attention, the World Health Organization and Patient Safety (A World Alliance for Safer Health Care), n. d., p. 2. 2.
 WHO Guideline on the Use of Safety-Engineered Syringes for Intramuscular, Intradermal and Subcutaneous Injections in Health-Care Settings, World Health Organisation, WHO/HIS/SDS/2015.5, p. 7.